Her current research interests include targeted nanoparticles in cancer therapy, choleterol-tergeted nanoparticles to overcome multidrug drug resistance and enhance cellular delivery, applications of proteiomics, metabolomics and lipidomics to develop nanomedicines, cationic nanoparticles and their mucosal/oral applications, cyclodextrin-based drug delivery, inkjet and 3D printed drug delivery systems, biomedical applications of nanoparticles to complex diseases like cancer and NAFLD and regulatory approaches on bioavailability/bioequivalence and simiilarity of non-biological complex drugs.